BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22293402)

  • 1. Myb: getting involved in EMT.
    Ramsay R
    Cell Cycle; 2012 Feb; 11(3):433-4. PubMed ID: 22293402
    [No Abstract]   [Full Text] [Related]  

  • 2. c-MYB and TGFβ: EMT's dynamic duo in breast cancer.
    Sala A
    Cell Cycle; 2012 Jan; 11(1):17. PubMed ID: 22186784
    [No Abstract]   [Full Text] [Related]  

  • 3. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
    Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
    Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
    Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-myb expression in ML-1 human myeloblastic leukemia cells by c-ets-1 protein.
    Bloch A; Liu XM; Wang LG
    Adv Enzyme Regul; 1995; 35():35-41. PubMed ID: 7572352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.
    Liu LY; Chang LY; Kuo WH; Hwa HL; Chang KJ; Hsieh FJ
    Comput Math Methods Med; 2014; 2014():813067. PubMed ID: 24639887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts.
    Piccinini G; Golay J; Flora A; Songia S; Luchetti M; Gabrielli A; Introna M
    J Invest Dermatol; 1999 Feb; 112(2):191-6. PubMed ID: 9989795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
    Chen L; Xu S; Zeng X; Li J; Yin W; Chen Y; Shao Z; Jin W
    Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):1-7. PubMed ID: 20043041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.
    Hugo HJ; Saunders C; Ramsay RG; Thompson EW
    J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):109-19. PubMed ID: 26193871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
    Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
    Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
    Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
    Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening.
    Kim D; You E; Jeong J; Ko P; Kim JW; Rhee S
    Sci Rep; 2017 Jul; 7(1):6847. PubMed ID: 28754957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma.
    Baraban E; Zhang PJ; Jaffer S; Lubin D; Feldman M; Bleiweiss IJ; Nayak A
    Histopathology; 2018 Dec; 73(6):897-903. PubMed ID: 30003572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
    Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
    Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
    Dahle Ø; Bakke O; Gabrielsen OS
    Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.
    Kaspar P; Zikova M; Bartunek P; Sterba J; Strnad H; Kren L; Sedlacek R
    Sci Rep; 2015 Oct; 5():15090. PubMed ID: 26462877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.